Amgen (AMGN)

Amgen, Inc. and AmerisourceBergen Corp. were sued on Friday by 14 U.S. states and the District of Columbia over an alleged kickback scheme designed to boost sales of Amgen's anemia drug, Aranesp.
New York Attorney General Andrew Cuomo announced the lawsuit, which was filed in federal court in Boston. It joins a related whistleblower lawsuit filed in the same court in 2006 and is one of many lawsuits accusing drugmakers of illegally marketing their products.

Nov 3 · 1:30:00 PM · Source: Reuters · Related: AmerisourceBergen
Track · email · face · Twitter · digg · COMMENTS
by Michael Oliveto